Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment

Ophthalmologica

Volumn 221, Issue 5, 2007, Pages 313-319

  Ladas, Ioannis D ^a   Kotsolis, Athanasios I ^a,b   Rouvas, Alexandros A ^a   Brouzas, Dimitrios ^a   Moschos, Marilita M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Age related macular degeneration; Occult choroidal neovascularization; Photodynamic therapy; Serous pigment epithelium detachment

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SEROUS PIGMENT EPITHELIUM DETACHMENT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM OF EYE; PROSPECTIVE STUDIES; RETINAL DETACHMENT; RETINAL PERFORATIONS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 34548321532     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104761     Document Type: Article

References (20)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999;117:1329-1345.
2. Bressler NM: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol 2001;119: 198-207.
3. Verteporfin in Photodynamic Therapy Study Group: Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
4. Macular Photocoagulation Study Group: Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for Evaluation and Treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-1257.
5. Yannnuzzi LA, Hope-Ross M, Slacter JS, Guyer DR, Sorenson JA, Ho AC, Sperber DE, Freund KB, Orlock DA: Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 1994;14:99-113.
6. Elman MJ, Fine SL, Murphy RP, Patz A, Auer C: The natural history of serous retinal pigment epithelial detachments in patients with age-related macular degeneration. Ophthalmology 1986;93:224-230.
7. Poliner LS, Olk RJ, Burgess D, Gordon ME: Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 1986;93:543-550.
8. Meredith TA, Braley RE, Aaberg TM: Natural history of serous detachments of retinal pigment epithelium. Am J Ophthalmol 1979;88:643-651.
9. Slacter JS, Yannnuzzi LA, Solrenson JA, Guyer DR, Ho AC, Orlock DA: A pilot study of indocyanine green videoangiography-guided laser photocoagulation treatment of occult choroidal neovascularization. Arch Ophthalmol 1994;112:465-472.
10. Lim JI, Aaberg TM, Capone A Jr, Sternberg P Jr: Indocyanine green angiography-guided photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment. Am J Ophthalmol 1997;123:524-532.
11. Brancato R, Introini U, Bolognesi G, Pacelli G, Trabucchi G, Pece A: ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration: indocyanine green angiography. Retina 2000;20:134-142.
12. Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, Weinberger D: Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 2004;122:453-459.
13. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R: Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-1961.
14. Mennel S, Meyer CH, Eggarter F, Peter S: Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy. Am J Ophthalmol 2005;140:758-760.
15. Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete P, Schmidt-Erfurth U: Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 2004;138:803-808.
16. Cantrill HL, Ramsay RC, Knobloch WH: Rips in the pigment epithelium. Arch Ophthalmol 1983;101:1074-1079.
17. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I: Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001;131:518-520.
18. Fung AE, Rosenfeld PJ, Reichel E: The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-1349.
19. Fossarello M, Peiretti E, Zucca I, Serra A: Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium. Eur J Ophthalmol 2004;14:568-571.
20. Augustin AJ, Schmidt-Erfurth U: Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;141:638-645.